Second Quarter 2026 Highlights Board composition change On February 23, 2026, the Board of Directors approved the departure of Mr
Although the injections are probably innocuous, they are unlikely to help your weight-loss efforts and may interfere with other medications, according to nutritionist Katherine Zeratsky of the MayoClinic.com
- *Deuruxolitinib*: The US FDA has approved deuruxolitinib, an oral JAK inhibitor, for the treatment of severe alopecia areata in adults
References Liu, Y
Disclaimer: This article is intended for B2B informational purposes for research institutions, compounding pharmacy professionals, and peptide manufacturers
Serum, spleen metabolomics and gut microbiota reveals effect of catalpol on blood deficiency syndrome caused by cyclophosphamide and acetylphenylhydrazine